Insulet (PODD) Non-Current Assets (2010 - 2026)
Insulet's (PODD) quarterly Non-Current Assets came in at $1.3 billion in Q2 2026, up 10.63% on a YoY basis from $1.2 billion in Q2 2025, and up 3.0% quarter-over-quarter from $1.3 billion in Q1 2026.
Analysis
Insulet (PODD) Non-Current Assets (2010 - 2026) Analysis & Trends
Insulet (PODD) has reported Non-Current Assets for 17 consecutive years, with $1.3 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non-Current Assets rose 10.63% year-over-year to $1.3 billion; the trailing twelve-month figure through Jun 2026 stood at $5.0 billion (up 6.34% YoY), and the FY2025 full-year result was $1.3 billion, up 6.69% from the prior year.
- Non-Current Assets rose to $1.3 billion in Q2 2026 per PODD's latest filing, from $1.3 billion in the prior quarter.
- Across five years, Non-Current Assets topped out at $1.3 billion in Q2 2026 and bottomed at $783.8 million in Q1 2022.
- Historically, Non-Current Assets has averaged $1.1 billion across 5 years, with a median of $1.1 billion in 2024.
- The sharpest annual moves came in 2022 and 2025: Non-Current Assets jumped 30.33% in 2022, then advanced 0.46% in 2025.
- Over 5 years, Non-Current Assets stood at $937.1 million in 2022, then advanced by 7.28% to $1.0 billion in 2023, then climbed by 19.01% to $1.2 billion in 2024, then rose by 6.69% to $1.3 billion in 2025, then increased by 3.1% to $1.3 billion in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $1.3 billion, $1.3 billion, and $1.3 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.76 Bn | 175.16 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | 11.33 Bn |
| 3 | Medtronic | 117.20 Bn | 108.39 Bn | 6.34 Bn | 68.92 Bn |
| 4 | Stryker | 104.01 Bn | 100.53 Bn | 4.50 Bn | 33.51 Bn |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn | 37.24 Bn |
| 6 | Edwards Lifesciences | 49.80 Bn | 45.55 Bn | 1.35 Bn | 7.05 Bn |
| 7 | Alcon | 33.03 Bn | 31.58 Bn | 1.68 Bn | 24.47 Bn |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | 2.37 Bn |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Insulet | 9.35 Bn | 8.82 Bn | 562.60 Mn | 1.32 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.32 Bn |
| Mar 31, 2026 | 1.28 Bn |
| Dec 31, 2025 | 1.28 Bn |
| Sep 30, 2025 | 1.17 Bn |
| Jun 30, 2025 | 1.19 Bn |
| Mar 31, 2025 | 1.19 Bn |
| Dec 31, 2024 | 1.20 Bn |
| Sep 30, 2024 | 1.16 Bn |
| Jun 30, 2024 | 1.13 Bn |
| Mar 31, 2024 | 1.01 Bn |
| Dec 31, 2023 | 1.01 Bn |
| Sep 30, 2023 | 996.60 Mn |
| Jun 30, 2023 | 964.30 Mn |
| Mar 31, 2023 | 959.10 Mn |
| Dec 31, 2022 | 937.10 Mn |
| Sep 30, 2022 | 837.10 Mn |
| Jun 30, 2022 | 804.60 Mn |
| Mar 31, 2022 | 783.80 Mn |
| Dec 31, 2021 | 719.00 Mn |
| Sep 30, 2021 | 692.00 Mn |